🚀 VC round data is live in beta, check it out!
Airdoc Valuation Multiples
Discover revenue and EBITDA valuation multiples for Airdoc and similar public comparables like User Local, Devyser Diagnostics, Fortifai, Owlet and more.
Airdoc Overview
About Airdoc
Beijing Airdoc Technology Co Ltd provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in China. Leveraging retinal imaging, multimodal data analyses, and AI deep learning algorithms, the company's solution differs from traditional chronic disease early detection and diagnosis, enabling non-invasive, accurate, fast, effective, and scalable detection and diagnosis of chronic diseases in both medical institutions and consumer healthcare providers. The Company derives revenue principally from the provision of AI-based software solutions, sales of hardware devices, and other services. Geographically, the company generates the majority of its revenue from Mainland China.
Founded
2015
HQ
Employees
282
Website
Sectors
Financials (LTM)
EV
$65M
Airdoc Financials
Airdoc reported last 12-month revenue of $25M.
In the same LTM period, Airdoc generated had net loss of ($4M).
Revenue (LTM)
Airdoc P&L
In the most recent fiscal year, Airdoc reported revenue of $23M and EBITDA of ($35M).
Airdoc expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $25M | XXX | $23M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $13M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 55% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($35M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (155%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (127%) | XXX | XXX | XXX |
| Net Profit | ($4M) | XXX | ($37M) | XXX | XXX | XXX |
| Net Margin | (14%) | XXX | (163%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Airdoc Stock Performance
Airdoc has current market cap of $157M, and enterprise value of $65M.
Market Cap Evolution
Airdoc's stock price is $1.53.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $65M | $157M | 0.5% | XXX | XXX | XXX | $-0.37 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAirdoc Valuation Multiples
Airdoc trades at 2.6x EV/Revenue multiple, and (1.8x) EV/EBITDA.
EV / Revenue (LTM)
Airdoc Financial Valuation Multiples
As of April 18, 2026, Airdoc has market cap of $157M and EV of $65M.
Equity research analysts estimate Airdoc's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Airdoc has a P/E ratio of (43.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $157M | XXX | $157M | XXX | XXX | XXX |
| EV (current) | $65M | XXX | $65M | XXX | XXX | XXX |
| EV/Revenue | 2.6x | XXX | 2.9x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (1.8x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (2.2x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 5.1x | XXX | XXX | XXX |
| P/E | (43.2x) | XXX | (4.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (2.7x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Airdoc Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Airdoc Margins & Growth Rates
Airdoc's revenue in the last fiscal year grew by 10%.
Airdoc's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Airdoc Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (155%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 113% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 48% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 71% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 65% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 182% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Airdoc Public Comps
See public comps and valuation multiples for other Artificial Intelligence and Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Airdoc | XXX | XXX | XXX | XXX | XXX | XXX |
| User Local | XXX | XXX | XXX | XXX | XXX | XXX |
| Devyser Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Fortifai | XXX | XXX | XXX | XXX | XXX | XXX |
| Owlet | XXX | XXX | XXX | XXX | XXX | XXX |
| TeraView Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Airdoc M&A Activity
Airdoc acquired XXX companies to date.
Last acquisition by Airdoc was on XXXXXXXX, XXXXX. Airdoc acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Airdoc
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAirdoc Investment Activity
Airdoc invested in XXX companies to date.
Airdoc made its latest investment on XXXXXXXX, XXXXX. Airdoc invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Airdoc
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Airdoc
| When was Airdoc founded? | Airdoc was founded in 2015. |
| Where is Airdoc headquartered? | Airdoc is headquartered in China. |
| How many employees does Airdoc have? | As of today, Airdoc has over 282 employees. |
| Is Airdoc publicly listed? | Yes, Airdoc is a public company listed on HKEX. |
| What is the stock symbol of Airdoc? | Airdoc trades under 02251 ticker. |
| When did Airdoc go public? | Airdoc went public in 2021. |
| Who are competitors of Airdoc? | Airdoc main competitors are User Local, Devyser Diagnostics, Fortifai, Owlet. |
| What is the current market cap of Airdoc? | Airdoc's current market cap is $157M. |
| What is the current revenue of Airdoc? | Airdoc's last 12 months revenue is $25M. |
| What is the current revenue growth of Airdoc? | Airdoc revenue growth (vs. last FY) is 10%. |
| What is the current EV/Revenue multiple of Airdoc? | Current revenue multiple of Airdoc is 2.6x. |
| Is Airdoc profitable? | No, Airdoc is not profitable. |
| What is the current net income of Airdoc? | Airdoc's last 12 months net income is ($4M). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.